Victor M Rivera

Title: Victor M Rivera: Innovator in Cancer Treatment

Introduction

Victor M Rivera is a notable inventor based in Arlington, MA (US). He has made significant contributions to the field of cancer treatment, particularly in developing methods for inhibiting cell proliferation in ALK-driven cancers. With a total of 2 patents, Rivera's work is at the forefront of medical innovation.

Latest Patents

One of Rivera's latest patents is focused on methods for treating patients with ALK-driven cancers that are refractory to existing treatments such as crizotinib, CH5424802, and ASP3026. This invention features a method that involves administering a specific compound to patients, which is crucial for those bearing an ALK mutation. Additionally, he has developed methods, kits, and compositions for characterizing ALK-driven cancers to determine the expression of ALK mutants. Another significant patent involves materials and methods related to conditional retention domains (CRDs). This patent discloses fusion proteins containing CRDs and cells that express these proteins, along with novel methods for producing target proteins in vivo.

Career Highlights

Throughout his career, Rivera has worked with prominent companies in the biotechnology sector, including Ariad Gene Therapeutics, Inc. and Ariad Pharmaceuticals, Inc. His work in these organizations has allowed him to contribute to groundbreaking research and development in cancer therapies.

Collaborations

Rivera has collaborated with esteemed colleagues such as Timothy P Clackson and James Edward Rothman. These partnerships have further enhanced his research and innovation in the field.

Conclusion

Victor M Rivera stands out as an influential inventor in the realm of cancer treatment, with a focus on ALK-driven cancers. His patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.